Literature DB >> 1334422

Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor.

G D Clark1, L T Happel, C F Zorumski, N G Bazan.   

Abstract

The biologically active lipid platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine; PAF) is a mediator of inflammatory and immune responses, and it accumulates in the brain during convulsions or ischemia. We have examined whether PAF may play a second messenger role in the central nervous system by studying effects on synaptic transmission in cultured hippocampal neurons. Carbamyl-PAF, a nonhydrolyzable PAF analog with a similar pharmacologic profile, augmented glutamate-mediated, evoked excitatory synaptic transmission and increased the frequency of spontaneous miniature excitatory synaptic events without increasing their amplitude or altering their time course. This compound had no significant effect on gamma-aminobutyric acid-mediated inhibitory synaptic responses. Lyso-PAF, the biologically inactive metabolic intermediate, had no effect on synaptic transmission. Moreover, the enhancement of excitatory synaptic transmission by carbamyl-PAF was blocked by a PAF receptor antagonist. These results indicate a specific presynaptic effect of PAF in enhancing excitatory synaptic transmission in cultured rat hippocampal neurons.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334422     DOI: 10.1016/0896-6273(92)90078-r

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  32 in total

Review 1.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

2.  Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties.

Authors:  P Bac; P Maurois; C Dupont; N Pages; J P Stables; P Gressens; P Evrard; J Vamecq
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

3.  Neuronal platelet-activating factor receptor signal transduction involves a pertussis toxin-sensitive G-protein.

Authors:  G D Clark; C F Zorumski; R S McNeil; L T Happel; T Ovella; S McGuire; G J Bix; J W Swann
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

4.  Properties and regulation of microsomal PAF-synthesizing enzymes in rat brain cortex.

Authors:  E Francescangeli; A Boila; G Goracci
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

5.  LAU-0901, a novel platelet-activating factor receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat.

Authors:  Ludmila Belayev; Larissa Khoutorova; Kristal Atkins; Alice Cherqui; Julio Alvarez-Builla; Nicolas G Bazan
Journal:  Brain Res       Date:  2008-12-03       Impact factor: 3.252

Review 6.  Lipid signaling in neural plasticity, brain repair, and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2005-08       Impact factor: 5.590

7.  Predominant expression of platelet-activating factor receptor in the rat brain microglia.

Authors:  M Mori; M Aihara; K Kume; M Hamanoue; S Kohsaka; T Shimizu
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

8.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

Authors:  Clive Bate; Mourad Tayebi; Alun Williams
Journal:  Mol Neurodegener       Date:  2010-04-08       Impact factor: 14.195

Review 10.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.